Davis Advantage for Maternal-Newborn Practice Test

An increased fibrinogen volume during pregnancy indicates a higher thrombus risk. Fibrinogen is a key protein in the blood that plays a crucial role in the coagulation process. During pregnancy, physiological changes lead to an increase in various clotting factors, including fibrinogen, which helps to prepare the body for the potential blood loss that can occur during delivery.

This increase is part of the body's compensatory mechanism to promote hemostasis and minimize the risk of hemorrhage. However, the elevated levels also contribute to a condition of hypercoagulability, leading to an increased risk of thrombus formation. Therefore, understanding this increase is critical for monitoring and managing the risks associated with both normal and high-risk pregnancies.

The other options do not accurately reflect the physiological changes that occur during pregnancy; a higher bleeding risk is not indicated by increased fibrinogen, and lower thrombus risk contradicts the hypercoagulable state associated with increased fibrinogen levels. Similarly, there is not no effect on clotting, as the increased fibrinogen actively enhances clot formation.